Acute porphyria: The cost of suspicion

American Journal of Medicine

Volumn 107, Issue 6, 1999, Pages 621-623

  Mattern, Shannon E T ^a   Tefferi, Ayalew ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; COPROPORPHYRIN; PORPHOBILINOGEN;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST CONTROL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCREENING; URINARY EXCRETION;

ACUTE DISEASE; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PATIENT SELECTION; PORPHYRIAS; PORPHYRINS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0032762980     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00305-8     Document Type: Article

References (25)

1. Moore M.R., McColl K.E., Fitzsimons E.J., Goldberg S.A. The porphyrias. Blood Rev. 4:1990;88-96.
2. Elder G.H. Genetic defects in the porphyrias types and significance . Clin Dermatol. 16:1998;225-233.
3. Tefferi A., Solberg L.A. Jr, Ellefson R.D. Porphyrias clinical evaluation and interpretation of laboratory tests . Mayo Clin Proc. 69:1994;289-290.
4. Pierach C.A., Weimer M.K., Cardinal R.A., et al. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria. JAMA. 257:1987;601.
5. Lundin G., Lee J.S., Thunell S., Anvret M. Genetic investigation of the porphobilinogen deaminase gene in Swedish acute intermittent porphyria families. Hum Genet. 100:1997;63-66.
6. Nordmann Y., Puy H., Da Silva V., et al. Acute intermittent porphyria prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France . J Intern Med. 242:1997;213-217.
7. Mustajoki P., Kauppinen R., Lannfelt L., et al. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland. J Intern Med. 231:1992;389-395.
8. Mustajoki P., Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand. 200:1976;171-178.
9. Ford R.E., Ou C.N., Ellefson R.D. Liquid-chromatographic analysis for urinary porphyrins. Clin Chem. 27:1981;397-401.
10. Kauppinen R., Mustajoki P. Prognosis of acute porphyria occurrence of acute attacks, precipitating factors, and associated diseases . Medicine (Baltimore). 71:1992;1-13.
11. Stein J.A., Tschudy D.P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore). 49:1970;1-16.
12. Elder G.H., Hift R.J., Meissner P.N. The acute porphyrias. Lancet. 349:1997;1613-1617.
13. Watson C.J. Porphyria. Adv Intern Med. 6:1954;235-299.
14. Goldberg A. Acute intermittent porphyria a study of 50 cases . Q J Med. 28:1959;183-209.
15. Ellefson R.D., Ford R.E. The porphyrias characteristics and laboratory tests . Regul Toxicol Pharmacol. 24:1996;S119-S125.
16. Elder G.H., Smith S.G., Smyth S.J. Laboratory investigation of the porphyrias. Ann Clin Biochem. 27:1990;395-412.
17. Gross U., Sassa S., Jacob K., et al. 5-Aminolevulinic acid dehydratase deficiency porphyria a twenty-year clinical and biochemical follow-up . Clin Chem. 44:1998;1892-1896.
18. Schreiber W.E., Jamani A., Pudek M.R. Screening tests for porphobilinogen are insensitive. The problem and its solution. Am J Clin Pathol. 92:1989;644-649.
19. With T.K. Hereditary coproporphyria and variegate porphyria in Denmark. Dan Med Bull. 30:1983;106-112.
20. Zaider E., Bickers D.R. Clinical laboratory methods for diagnosis of the porphyrias. Clin Dermatol. 16:1998;277-293.
21. Gross U., Honcamp M., Doss M.O. Heterogeneity of acute intermittent porphyria a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany . Eur J Clin Chem Clin Biochem. 34:1996;613-618.
22. Hindmarsh J.T. Enzyme assays and the porphyrias which tissues and when indicated . Clin Dermatol. 16:1998;245-250.
23. Mustajoki S., Pihlaja H., Ahola H., et al. Three splicing defects, an insertion, and two missense mutations responsible for acute intermittent porphyria. Hum Genet. 102:1998;541-548.
24. Daniell W.E., Stockbridge H.L., Labbe R.F., et al. Environmental chemical exposures and disturbances of heme synthesis. Environ Health Perspect. 105:(suppl 1):1997;37-53.
25. Hahn M., Bonkovsky H.L. Multiple chemical sensitivity syndrome and porphyria. A note of caution and concern. Arch Intern Med. 157:1997;281-285.